The UAE cardiovascular devices market size was estimated at USD 247.90 million in 2024 and is projected to reach USD 410.52 million by 2033, growing at a CAGR of 5.75% from 2025 to 2033. Increased incidence of cardiovascular disease is one of the key aspects driving the market's growth.
According to an article published by the American Heart Association, Inc. in November 2024, in the UAE, cardiovascular diseases (CVDs) represent the primary health challenge, being responsible for approximately 36.7% of all fatalities, nearly double the proportion of deaths linked to cancer. This high disease burden underscores the urgent need for advanced diagnostic, monitoring, and treatment solutions, thereby driving demand for cardiovascular devices in the country. The growing prevalence of risk factors such as obesity, diabetes, and sedentary lifestyles further amplifies the requirement for innovative medical technologies, positioning the UAE cardiovascular devices market for continued growth.
Moreover, the increasing prevalence of CVD drives the growth of the market. According to a BioMed Central Ltd article published in December 2024, in the UAE, the age-standardized cardiovascular disease (CVD) prevalence was estimated at around 11,066.8 cases per 100,000 population, marking the highest rate in North Africa and the Middle East. This significant disease burden underscores a substantial demand for advanced cardiovascular devices to support early diagnosis, effective treatment, and long-term management of heart-related conditions. The high prevalence rate reflects the growing need for innovative medical technologies, such as minimally invasive surgical tools, advanced monitoring systems, and next-generation implantable devices, to address the escalating cardiovascular health challenges within the country.
This product will be delivered within 1-3 business days.
According to an article published by the American Heart Association, Inc. in November 2024, in the UAE, cardiovascular diseases (CVDs) represent the primary health challenge, being responsible for approximately 36.7% of all fatalities, nearly double the proportion of deaths linked to cancer. This high disease burden underscores the urgent need for advanced diagnostic, monitoring, and treatment solutions, thereby driving demand for cardiovascular devices in the country. The growing prevalence of risk factors such as obesity, diabetes, and sedentary lifestyles further amplifies the requirement for innovative medical technologies, positioning the UAE cardiovascular devices market for continued growth.
Moreover, the increasing prevalence of CVD drives the growth of the market. According to a BioMed Central Ltd article published in December 2024, in the UAE, the age-standardized cardiovascular disease (CVD) prevalence was estimated at around 11,066.8 cases per 100,000 population, marking the highest rate in North Africa and the Middle East. This significant disease burden underscores a substantial demand for advanced cardiovascular devices to support early diagnosis, effective treatment, and long-term management of heart-related conditions. The high prevalence rate reflects the growing need for innovative medical technologies, such as minimally invasive surgical tools, advanced monitoring systems, and next-generation implantable devices, to address the escalating cardiovascular health challenges within the country.
UAE Cardiovascular Devices Market Report Segmentation
This report forecasts revenue growth at country levels and analyzes the industry trends in each sub-segments from 2021 to 2033. The analyst has segmented the UAE cardiovascular devices market report based on product, distribution channel, and end use:Product Outlook (Revenue, USD Million, 2021-2033)
- Diagnostic & Monitoring
- ECG
- Implantable Cardiac Monitors
- Holter Monitors
- Mobile Cardiac Telemetry
- MRI
- Cardiovascular Ultrasound
- 2D
- 3D/4D
- Doppler
- Cardiac Diagnostic Catheters
- PET Scanner
- Surgical Devices
- Cardiac Resynchronization Therapy (CRT)
- Implantable Cardioverter Defibrillators (ICDs)
- Pacemakers
- Coronary Stents
- Catheters
- Guidewires
- Cannula
- Valves
- Occlusion Devices
Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Online
- Offline
End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. UAE Cardiovascular Devices Market Variables, Trends & Scope
Chapter 4. UAE Cardiovascular Devices Market: Product Estimates & Trend Analysis
Chapter 5. UAE Cardiovascular Devices Market: Distribution Channel Estimates & Trend Analysis
Chapter 6. UAE Cardiovascular Devices Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this UAE Cardiovascular Devices market report include:- Abbott
- GE HealthCare
- Edwards Lifesciences Corporation
- Siemens Healthineers AG
- Canon Medical Systems
- B. Braun SE
- LivaNova, Inc.
- Cardinal Health
- Medtronic
- Boston Scientific Corporation
- W. L. Gore & Associates, Inc.
- BIOTRONIK SE & Co. KG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | August 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 247.9 Million |
| Forecasted Market Value ( USD | $ 410.52 Million |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | United Arab Emirates |
| No. of Companies Mentioned | 13 |
